Biomarkers for cervical cancer.
A cervical marker gene technology, applied in the field of detection of susceptibility to cervical cancer, can solve the problem of low specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0064] Experimental part
[0065] patients and methods
[0066] general strategy
[0067] To characterize the DNA methylation of CIN2 / 3 lesions and identify novel methylation markers of CIN2 or higher (CIN2+), we applied the following strategy (see figure 1 ): First, the MBD of human MECP2 was used to enrich for methylated DNA, and subsequently in two samples from 18 CIN2 / 3 lesions (6 CIN2 and 12 CIN3), 20 normal cervical and healthy volunteer leukocyte DNA. paired-end sequencing (MethylCap-seq) on DNA isolated from fresh-frozen macro-dissected epithelial tissues. To identify differentially methylated regions (DMRs), we retrieved reads from promoter and exonic regions. We selected methylation markers that showed significant differences between normal and CIN2 / 3 cervixes and that the white blood cell count must also be low to prevent false positive results. Markers were graded according to high specificity (unmethylated in normal cervix) and high sensitivity (methylated in...
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com